[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
date : 6/26/2024
Tags: NCDs, Precision Cancer Medicine
Non-communicable diseases (NCDs), including cancer, are gaining prominence as significant health threats in low and middle-income countries (LMICs). However, they still lack sufficient traction and investment. Since its launch in 2017 as a Union for International Cancer Control (UICC) initiative and its registration as an independent Swiss foundation in 2019, City Cancer Challenge (C/Can) has been supporting cities worldwide in their efforts to enhance access to equitable and quality cancer care. This event showcased C/Can’s innovative approach to cancer care in developing countries through case studies and provide an opportunity to discuss future collaboration opportunities with Japanese cancer and NCD stakeholders through networking sessions.
[Event Overview]
- Date & Time: Thursday, June 20, 2024, from 15:00 to 17:00 JST
- Format: In-Person (no virtual attendance available)
- Venue: Global Business Hub Tokyo
(Grand Cube 3F, Otemachi Financial City, 1-9-2, Otemachi, Chiyoda-ku, Tokyo, 100-0004 JAPAN) - Language: Japanese and English, with simultaneous interpretation
- Participation fee: Free
- Co-host: City Cancer Challenge (C/Can), Health and Global Policy Institute (HGPI)
[Program] (Titles omitted; in no particular order)
15:00-15:05 | Opening Remarks |
Hajime Inoue (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare) | |
15:05-15:10 | Explanatory Introduction |
Ryoji Noritake (CEO, Board Member, Health and Global Policy Institute (HGPI)) | |
15:10-15:30 | Keynote Speech “Current Status of Cancer Care in Developing Countries and the C/Can Model” |
Isabel Mestres (CEO, C/Can) | |
15:30-16:00 | Discussion “Voices from the Frontline and Expectations for Japan” |
(All speakers and attendees at the venue)
|
|
16:00-16:05 |
Remarks |
Ken Shibusawa (CEO, Shibusawa and Company, Inc.) | |
16:05-16:15 | Q&A |
16:15-17:00 | Networking Session |
About City Cancer Challenge (C/Can)
Since its launch in 2017 as a Union for International Cancer Control (UICC) initiative and its registration as an independent Swiss foundation in 2019, City Cancer Challenge (C/Can) has been supporting cities worldwide in their efforts to enhance access to equitable and quality cancer care. Cancer is the second leading cause of premature death globally, with over 10 million cancer deaths in 2020. Low-and middle-income countries account for seven out of every ten deaths from cancer and the impact of these premature deaths further strains economies. By implementing tailored solutions, countries have the potential to save thousands of lives each year in an effective, sustainable, and scalable manner. C/Can has developed and implemented an innovative model that empowers local stakeholders such as policymakers, hospitals managers, healthcare professionals, academics, civil society representatives and patients to evaluate, plan and implement practical and sustainable solutions to improve cancer care at city level. For C/Can, cities offer a distinct environment to drive innovation in cancer care, which can be expanded to a national level. C/Can is present in 14 cities across Africa, Asia, Europe and Latin America. The global network continues to expand, with an open application process launched in 2023 to on-board new cities in 2025.
Top Research & Recommendations Posts
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] The Women’s Health Promotion Project “Policy proposal for Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (July 31, 2024)
- [Reserch Report] Antimicrobial Resistance (AMR) Measures in Sweden (November 21, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Announcement] Signs “A COP29 for People and Planet: Recommendations from the international health and climate community” (November 11, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
Featured Posts
-
2024-11-21
[Reserch Report] Antimicrobial Resistance (AMR) Measures in Sweden (November 21, 2024)
-
2024-11-25
[Registration Open] (Webinar) The 130th HGPI Seminar “Marking a Decade of the Act on Medical Care for Patients With Intractable Diseases: Connecting Intractable Diseases and Society From the Perspective of a Media Professional and Family Member” (January 28, 2025)
-
2024-11-29
[Registration Open] (Webinar) The 129th HGPI Seminar “The Connection Between Planetary Environment and Human Health as Seen Through the JECS and Future Expectations” (December 23, 2024)
-
2024-12-01
[Activity Report] Announcing the Launch of the Japan’s Patient Expert Platform (J-PEP) Website (December 1, 2024)